Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

André, Thierry, Shiu, Kai-Keen, Kim, Tae Won, Jensen, Benny Vittrup, Jensen, Lars Henrik, Punt, Cornelis, Smith, Denis, Garcia-Carbonero, Rocio, Benavides, Manuel, Gibbs, Peter, de la Fouchardiere, Christelle, Rivera, Fernando, Elez, Elena, Bendell, Johanna, Le, Dung T., Yoshino, Takayuki, Van Cutsem, Eric, Yang, Ping, Farooqui, Mohammed Z.H., Marinello, Patricia, Diaz, Luis A.·2020·New England Journal of Medicine

DOI 10.1056/nejmoa2017699

Cited by (1,003)

Items 901–1,000 of 1,003

Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers
Shota Kikuchi, Jason C. Green, Donald C. Rogness, Betty Lam, Zachary A. Owyang, Robert D. Malmstrom, Ali Tabatabaei, Aaron Nathan Snead, Melissa A. Hoffman, Steffen M. Bernard et al. · 2025 · Journal of Medicinal Chemistry
Exploiting the unique properties of nanobodies: enhancing therapeutics, drug delivery, and targeted diagnostics
Lisa Blank, Giulia Pander, Eric Mühlberg, Walter Mier, Philipp Uhl · 2025 · Drug Discovery Today
Minimizing the risk of small-for-size syndrome after liver surgery
Michail Papamichail, Michail Pizanias, Nigel David Heaton · 2021 · Hepatobiliary & pancreatic diseases international
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
Elena Élez, Núria Mulet-Margalef, Miriam Sansó, Fiorella Ruíz‐Pace, Francesco Mattia Mancuso, Raquel Comas, Javier Ros, Guillem Argilés, Giulia Martini, Enrique Sanz‐García et al. · 2022 · International Journal of Molecular Sciences
POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
Mihir Bikhchandani, Farin F. Amersi, Andrew Eugene Hendifar, Alexandra Gangi, Arsen Osipov, Karen N. Zaghiyan, Katelyn M. Atkins, May Thet Cho, Francesca Paola Aguirre, Dennis J. Hazelett et al. · 2023 · Genes
A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World Series
Ioannis A. Voutsadakis · 2023 · Current Oncology
Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
X. Cheng, Xiaozheng Li, Xudong Yang, Shaojun Fang, Zhenyu Wang, Tingting Liu, Mengyao Zheng, Maocai Zhai, Zhibin Yang, Tao Shen · 2023 · Cureus
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
Juan Hui, Mingzhen Zhou, Guangzhou An, Hui Zhang, Yuanyuan Lu, Xin Wang, Xiaodi Zhao · 2023 · Cancer Biology and Medicine
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence
Poorva Vaidya, Ezra E.W. Cohen · 2023 · Clinical Cancer Research
Immune-related cardiovascular toxicities of PD-1/PD-L1 inhibitors in solid tumors: an updated systematic review and meta-analysis
Chi Zhang, Fengtao Wei, Wenhan Ma, Jingbo Zhang · 2024 · Frontiers in Immunology
Preoperative chemotherapy in upfront resectable colorectal liver metastases: New elements for an old dilemma?
L. Bernardi, Raffaello Roesel, Davit L. Aghayan, Pietro Edoardo Majno-Hurst, Sara De Dosso, Alessandra Cristaudi · 2024 · Cancer Treatment Reviews
Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset
Marco Maria Germani, Guglielmo Vetere, Fiorenza Santamaria, Rossana Intini, Filippo Ghelardi, Maria Bensi, Alessandra Boccaccino, Alessandro Minelli, Martina Carullo, Paolo Ciracì et al. · 2024 · ESMO Open
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
Robert William Lentz, Tyler J. Friedrich, Patrick Jud Blatchford, Kimberly Rae Jordan, Todd M. Pitts, Hannah Ruth Robinson, Sarah Lindsey Davis, Sunnie S. Kim, Alexis Diane Leal, Mathew R. Lee et al. · 2024 · Clinical Cancer Research
Biomarker Testing Disparities in Metastatic Colorectal Cancer
Saad Sabbagh, María Herrán, Ali Hijazi, Iktej Singh Jabbal, Mohamed Mohanna, Barbara Geraldine Dominguez, Mira Itani, Kaylee Sarna, Hong Liang, Zeina A. Nahleh et al. · 2024 · JAMA Network Open
Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer
Rui Zhang, Chang Su, Yong-liang Jia, Menglu Xing, Shuiling Jin, Hong Zong · 2024 · Biomedicine & Pharmacotherapy
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trial
Zi-Tong Zhang, Weiwei Xiao, Li Li, Xiao-Jun Wu, Qiaoxuan Wang, Hui Chang, Xue Tian, Jiang Wu, Junzhong Lin, Rong-Xin Zhang et al. · 2024 · EClinicalMedicine
pH and ROS Dual‐Responsive Autocatalytic Release System Potentiates Immunotherapy of Colorectal Cancer
Qianyi Su, Zhenyu Wang, Peishan Li, Xin Wei, Jisheng Xiao, Xiaopin Duan · 2024 · Advanced Healthcare Materials
Clinical research progress of fruquintinib in the treatment of malignant tumors
Shihao Zhao, Wenhui Wang, Jingyi Li, Zhigang Li, Zhan-Bo Liu, Shunchao Zhang, Zhaoqi Chen, Hongling Wang, Xiangqi Wang, Juntao Wang · 2024 · Investigational New Drugs
PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis
Dakota B. Poschel, John David Klement, Alyssa D. Merting, Chunwan Lu, Yang Zhao, Dafeng Yang, Wei Lie Xiao, Huabin Zhu, Ponnala Rajeshwari, Michael L. Toscano et al. · 2024 · Cell Reports
XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial
Maggie J. Phillips, Olatunji Boladale Alese, Natalie K. Horvat, Emily R. Greene, Olumide B. Gbolahan, Kathleen Coleman, Deon Bryant Doxie, Vaunita C Parihar, Zaid K Mahdi, Ashley A. McCook‐Veal et al. · 2025 · OncoImmunology
CometChip enables parallel analysis of multiple DNA repair activities
Jing Ge, Le P. Ngo, Simran Kaushal, Ian Jun Jie Tay, Elina Thadhani, Jennifer E. Kay, Patrizia Mazzucato, Danielle N. Chow, Jessica L. Fessler, David M. Weingeist et al. · 2021 · DNA repair
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis
Chengjing Zhou, Ting Jiang, Rongzhen Li, Yan Yuan, Weihao Xie, Xiaoxue Huang, Qiaoxuan Wang, Hui Chang, Gong Chen, Yuhong Li et al. · 2021 · 癌症：英文版
Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age
Joseph R. Wooley, Marta Peñas-Prado · 2021 · Cancers
Chinese consensus on prevention of colorectal neoplasia (2021, S hanghai)
Jing-Yuan Fang · 2022 · Journal of Digestive Diseases
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells
Mandy Gruijs, Rens Braster, Marije B. Overdijk, Tessa Hellingman, Sandra A.B.W. Verploegen, Rianne Korthouwer, Berend J. van der Wilk, Paul W.H.I. Parren, Hans J. van der Vliet, Marijn Bögels et al. · 2022 · Journal of Oncology
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
Gerardo Rosati, Giuseppe Aprile, Alfredo Colombo, Stefano Sergio Cordio, Marianna Giampaglia, Alessandro Cappetta, Concetta Maria Porretto, Alfonso De Stefano, Domenico Bilancia, Antonio Avallone · 2022 · Biomedicines
Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review
Louise André, Gabriel Antherieu, Amélie Boinet, Judith Bret, Thomas Gilbert, Rabia Boulahssass, Claire Falandry · 2022 · Cancers
Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker
Phoenix D. Bell, Reetesh K. Pai · 2022 · Histopathology
Clinical implication and immunological landscape analyses of ANLN in pan‐cancer: A new target for cancer research
Lan Zhang, Yongyue Wei, Yan He, Xiaping Wang, Zebo Huang, Libing Sun, Jie Chen, Qingyi Zhu, Xin Min ZHOU · 2022 · Cancer Medicine
Implication of gut microbiome in immunotherapy for colorectal cancer
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Georgios Aloizos, Ariadne Tsagarakis, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Athanasios G. Papavassiliou et al. · 2022 · World Journal of Gastrointestinal Oncology
Intraindividual Tumor Heterogeneity of Mismatch Repair Status in Metastatic Colorectal Cancer
Qianpeng Huang, Tao Yu, Lei Li, Qi Zhang, Shiyao Zhang, Baosong Li, Xiaoping Li, Wanyi Xiao, Gang Liu · 2022 · Applied immunohistochemistry & molecular morphology
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
C. Lisanti, Debora Basile, Silvio Ken Garattini, Annamaria Parnofiello, Carla Corvaja, Francesco Cortiula, Elisa Bertoli, Elena Ongaro, Luisa Foltran, Mariaelena Casagrande et al. · 2022 · Cancers
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Birgit S. Geurts, Thomas Battaglia, Jade M. van Berge Henegouwen, Laurien Joanna Zeverijn, Gijs F. de Wit, Louisa Rose Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Paul Roepman, Wendy W.J. de Leng et al. · 2023 · BMC Cancer
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
Pina Ziranu, Andrea Pretta, Marta Pozzari, Antonio Maccioni, Manuela Badiali, Daniela Fanni, Eleonora Lai, Clelia Donisi, Mara Persano, Clara Gerosa et al. · 2023 · Scientific Reports
Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers
Yuba R. Bhandari, Vinod Krishna, Rachael Powers, Sehej Parmar, Sara-Jayne Thursby, Ekta Gupta, Ozlem Kulak, Prashanth Ravishankar Gokare, Joke Reumers, Liesbeth Van Wesenbeeck et al. · 2023 · Proceedings of the National Academy of Sciences
MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection
Yang Cao, Dan Wang, Jin Wu, Zhanxin Yao, Si Shen, Chao Niu, Ying Liu, Pengcheng Zhang, Quannian Wang, Jinhao Wang et al. · 2023 · Briefings in Bioinformatics
HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation
Wei Zhang, Jie-Gang Yang, Bei-Ke Wang, You-Tao Lu, Jing-Bo Yang, Wen-Qun Zhong, Zi-Yan Yu, Zhiyuan Qin, Bolin Xiao, Kui-Ming Wang et al. · 2023 · Cell Reports
Challenges in Crohn’s Disease Management after Gastrointestinal Cancer Diagnosis
Claudio Fiorillo, Carlo Alberto Schena, Giuseppe Quero, Vito Laterza, Daniela Pugliese, Giuseppe Privitera, Fausto Rosa, Tommaso Schepis, Lisa Salvatore, Brunella Di Stefano et al. · 2021 · Cancers
Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion
Salman Chaudhry, Ryan Courtney Fields, Patrick M. Grierson, Kian‐Huat Lim · 2021 · Cancers
KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients
Cairui Xu, Kangli Cao, Along Ma, Meijuan Zheng, Yuanhong Xu, Ling Tang · 2025 · Cancer Immunology Immunotherapy
Tertiary lymphoid structures in the microenvironment of colorectal cancer: exploring new therapeutic targets
Nan-Nan Dai, Man-Yi Hu, Jianping Wang, Zhi-Hui Dai, Li Xu, Tai‐Wei Ye · 2025 · Cancer Immunology Immunotherapy
Oncolytic Virotherapy in Solid Tumors: A Current Review
Courtney Chen, Jennifer Cillis, Supriya Deshpande, Anthony K. Park, Hannah Valencia, Sang In Kim, Jianming Lu, Yoya Vashi, Annie Yang, Zhifang Zhang et al. · 2025 · BioDrugs
The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy
Ola Hussein, Menatallah Rayan, Tasnim R. Matarid, Dana H. Elkhalifa, Hanan H. Abunada, Lubna Therachiyil, Ashraf A. Khalil, Shahab Uddin M.S., Cristina Maccalli, Hesham Mohamed Korashy · 2025 · Journal of Experimental & Clinical Cancer Research
Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
Jun Gong, Francesca Paola Aguirre, Dennis J. Hazelett, Rocio Alvarez, Lisa Zhou, Andrew Eugene Hendifar, Arsen Osipov, Karen N. Zaghiyan, May Thet Cho, Alexandra Gangi et al. · 2022 · Molecular and Clinical Oncology
Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory
Mikal El‐Hajjar, Lara Gerhardt, Megan M Y Hong, Mithunah Krishnamoorthy, René Figueredo, Xiufen Zheng, James D. Koropatnick, Saman Maleki Vareki · 2022 · Molecular Therapy
The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, Yezhou Ding, Kehui Liu, Lihong Qu, Gangde Zhao et al. · 2023 · Frontiers in Pharmacology
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system
Chen Zhu, Gang Han, Bin Yan Wu · 2023 · BMC Health Services Research
Optimizing the first-line treatment for metastatic colorectal cancer
Sara Cherri, Ester Oneda, Laura Zanotti, Alberto Zaniboni · 2023 · Frontiers in Oncology
The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells
Hirotsugu Saiki, Yoshito Hayashi, Shunsuke Yoshii, Eiji Kimura, Kentaro Nakagawa, Minoru Kato, Ryotaro Uema, Takanori Inoue, Akihiko Sakatani, Takeo Yoshihara et al. · 2023 · International Journal of Oncology
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
Stephen H Rankin, Benjamin Michael Peter Elyan, Robert J. Jones, Balaji Venugopal, Patrick Barry Mark, Jennifer Susan Lees, Mark Colquhoun Petrie, Ninian N. Lang · 2024 · JACC CardioOncology
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability
Mathilde Moreau, Emily Linda Alouani, Clémence Flecchia, Antoine Falcoz, Claire Gallois, Édouard Auclin, Thierry André, Romain Cohen, Antoine Hollebecque, Anthony Turpin et al. · 2024 · European Journal of Cancer
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications
Juan Carlos Laguna, Belén Pastor, I. Nalda, Sara Hijazo‐Pechero, Cristina Teixidó, Míriam Potrony, Joan Anton Puig‐Butillé, Laura Mezquita · 2024 · British Journal of Cancer
Survival trends for left and right sided colon cancer using population‐based SEER database: A forty‐five‐year analysis from 1975 to 2019
Mark Bilinyi Ulanja, Kwabena Oppong Asafo-Agyei, Vijay Neelam, Bryce David Beutler, Daniel Antwi‐Amoabeng, Samuel Governor, Ganiyu A. Rahman, Francis Tanam Djankpa, Reginald N. Ulanja, Grace B. Nteim et al. · 2024 · Cancer Medicine
The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis
Pengfei Zhao, Ting Zhao, Lihong Yu, Wenming Ma, Wenyu Liu, Chenning Zhang · 2024 · Frontiers in Oncology
Mutational signatures of colorectal cancers according to distinct computational workflows
Paolo Battuello, Giorgio Corti, Alice Bartolini, Annalisa Lorenzato, Alberto Sogari, Mariangela Russo, Federica Di Nicolantonio, Alberto Bardelli, Giovanni Crisafulli · 2024 · Briefings in Bioinformatics
Novel drug delivery systems in colorectal cancer: Advances and future prospects
Raj Kamal, Ankit Awasthi, Priyanka Paul, Mohammad Shabab Mir, Sachin Kumar Singh, Kamal Dua · 2024 · Pathology - Research and Practice
Clinical characteristics and influencing factors of anti-PD-1/PD-L1-related severe cardiac adverse event: based on FAERS and TCGA databases
Xitong Cheng, Jierong Lin, Bitao Wang, Shunming Huang, Maobai Liu, Jing Yang · 2024 · Scientific Reports
HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancer
Zhuang Sun, Mengyuan Shi, Jinhong Xia, Xin Li, Nan Chen, Hanyang Wang, Zhaoya Gao, Jinying Jia, Yang Peng, Dengbo Ji et al. · 2025 · Journal for ImmunoTherapy of Cancer
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview
Zhaoguo Lin, Pawel Rasinski, Ted Nilsson, Maria Holstensson, Yangmeihui Song, August Blomgren, Warissara Jutidamrongphan, Kalyani Pandya, Jimin Hong, Axel Rominger et al. · 2025 · Seminars in Nuclear Medicine
CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8+ T cell exhaustion in colorectal cancer
Tongsen Zheng, Chujie Ding, Shihui Lai, Yang Gao, Cheng Lyu, Caiqi Liu, Jiaqi Shi, Xiaobo Li, Mingwei Li, Hongxue Meng et al. · 2025 · Nature Cell Biology
Mismatch Repair Status Correlates with Survival in Young Adults with Metastatic Colorectal Cancer
Dana M. van der Heide, Kiran Kalyan Turaga, Carlos H.F. Chan, Scott K. Sherman · 2021 · Journal of Surgical Research
Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules
Li-Cheng Tan, Wanlin Liu, Xiaoli Zhu, Pengcheng Yu, Xiao Hua SHI, Pei-Zhen Han, Ling Zhang, Liang‐Yu Lin, А. А. Семенов, Yu Wang et al. · 2021 · Frontiers in Oncology
Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates
Hee Yeon Lee, In Sook Woo · 2021 · Cancers
Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Trials
Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori · 2021 · Cureus
Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations
Zachary Ryan McCaw, Dae Hyun Kim, L. J. Wei · 2022 · JNCI Cancer Spectrum
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling
Ian M. Silverman, Meijuan Li, Karthikeyan Murugesan, Melanie A. Krook, Milind M. Javle, Robin Kate Kelley, Mitesh J. Borad, Sameek Roychowdhury, Wei Meng, Bahar Yilmazel et al. · 2022 · Journal of Molecular Diagnostics
GOBLET: a phase I/II study of pelareorep and atezolizumab +/- chemo in advanced or metastatic gastrointestinal cancers
Maike Collienne, Houra Loghmani, Thomas Charles Heineman, Dirk Arnold · 2022 · Future Oncology
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
Davide Ciardiello, Cinzia Chiarazzo, Vincenzo Famiglietti, Angela Damato, Carmine Pinto, Maria Giulia Zampino, Grazia Castellano, Lorenzo Gervaso, Alberto Zaniboni, Ester Oneda et al. · 2022 · ESMO Open
The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study
Mifen Chen, Zhenghang Wang, Zimin Liu, Ning Liu, Weijia Jia Fang, Hangyu Zhang, Xuan Shun Jin, Jiayi Li, Weifeng Zhao, Huajun Qu et al. · 2022 · Cancers
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
Younes Belkouchi, Laëtitia Nebot-Bral, Littisha Lawrance, Michèle Kind, Clémence David, Samy Ammari, Paul-Henry Cournède, Hugues Talbot, Perrine Vuagnat, Cristina Smolenschi et al. · 2022 · Frontiers in Oncology
Regorafenib with or without a programmed cell death protein 1 antibody as third‐line treatment for microsatellite stable metastatic colorectal cancer
Wenzhuo He, Lei Wang, Chenxi Yin, Jiahong Yi, Ya‐Nan Jin, Chang Jiang, Guifang Guo, Liangping Xia · 2022 · Cancer Medicine
Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy
Xiaotao Zhang, Hongzhen Tang, Haitao Luo, Huiping Lu, Chaohu Pan, Haiming Yu, Linlin Zhang, Yaping Guan, Lan Yu, Huili Chu et al. · 2022 · Frontiers in Genetics
Immunotherapy combined with radiotherapy to reverse immunosuppression in microsatellite stable colorectal cancer
Chenxi Wu, Yingjie Shao, Wendong Gu · 2023 · Clinical & Translational Oncology
Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis
Jina Choi, Nayoung Kim, Ryoung Hee Nam, Jin Won Kim, Chin‐Hee Song, Hee Young Na, Gyeong Hoon Kang · 2023 · PLoS ONE
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Yong Yang, An Huang, Zhuang Sun, Haopeng Hong, Nam KYu Kim, Jin Fa Gu · 2023 · Holistic Integrative Oncology
Prognostic value of Lynch syndrome, BRAFV600E, and RAS mutational status in dMMR / MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts
Koen Zwart, Frederieke H. van der Baan, Romain Cohen, Thomas Aparicio, Christelle de la Fouchardière, Thierry Lecomte, Cornelis J.A. Punt, David Sefrioui, Rik Jasper Verheijden, Geraldine R. Vink et al. · 2023 · Cancer Medicine
EMAST Type of Microsatellite Instability—A Distinct Entity or Blurred Overlap between Stable and MSI Tumors
Kristina Vuković Đerfi, Anamarija Salar, Tamara Čaćev, Sanja Kapitanović · 2023 · Genes
Stakeholders’ views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology
Rosie O’Shea, Nicole Marion Rankin, Maira Kentwell, Margaret Gleeson, Katherine Tucker, Heather Hampel, Natalie Jayne Taylor, Sarah Jayne Lewis · 2021 · European Journal of Human Genetics
Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis
Hao Xu, Qianhui Xu, Lu Yin · 2021 · Cancer Cell International
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice
Paola Parente, Umberto Malapelle, Valentina Angerilli, Mariangela Balistreri, Sara Lonardi, Salvatore Pucciarelli, Caterina De Luca, Francesco Pepe, Gianluca Russo, Elena Vigliar et al. · 2022 · Journal of Clinical Pathology
High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma
Yixing Yang, Fengwen Ye, Tianxiang Xia, Qianwen Wang, Yujie Zhang, Jun Du · 2022 · BMC Cancer
Personalizing first-line treatment in advanced colorectal cancer: Present status and future perspectives
Rodrigo Motta, Santiago Cabezas-Camarero, Cesar Torres-Mattos, Alejandro Riquelme, Ana Calle, Paola Montenegro, Miguel J. Sotelo · 2021 · Journal of Clinical and Translational Research
Neoadjuvant Treatment of Mismatch Repair–Deficient Colon Cancer — Clinically Meaningful?
Andrea Cercek · 2024 · New England Journal of Medicine
ctDNA-guided adjuvant immunotherapy in colorectal cancer
Nicholas B. Burley, Yurhee Lee, Louisa Liu, Alexandra Gangi, Yosef Y. Nasseri, Katelyn M. Atkins, Karen N. Zaghiyan, Zuri A. Murrell, Arsen Osipov, Andrew Eugene Hendifar et al. · 2024 · Immunotherapy
Does side matter? Deciphering mechanisms that underpin side-dependent pathogenesis and therapy response in colorectal cancer
Harrison J Boka, Rebekah M. Engel, Christine Georges, Paul John McMurrick, Helen E. Abud · 2025 · Molecular Cancer
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer
Eleonora Piumatti, Pietro Paolo Vitiello, Vito Amodio, Alberto Bardelli, Giovanni Germano · 2025 · Cancer Research
Gastrointestinal cancer: molecular pathogenesis and targeted therapy
Yang Jin, Xiaobo He, Yanfeng Wu · 2025 · Molecular Biomedicine
PET/MRI in colorectal and anal cancers: an update
Vetri Sudar Jayaprakasam, Semra İnce, Garima Suman, Pankaj Nepal, Thomas A. Hope, Raj Mohan Paspulati, Tyler J. Fraum · 2023 · Abdominal Radiology
HAMLET effect on cell death and mitochondrial respiration in colorectal cancer cell lines with KRAS/BRAF mutations
Justas Žilinskas, Darius Stukas, Aldona Jasukaitienė, Jurgita Šapauskienė, Rasa Banienė, Sonata Trumbeckaitė, Saulius Švagždys, Marco Cicciù, Žilvinas Dambrauskas, Antanas Gulbinas et al. · 2023 · Journal of Cancer Research and Clinical Oncology
Clinical Trials of Cellular Therapies in Solid Tumors
Simona Secondino, Costanza Canino, Domiziana Alaimo, Marta Muzzana, Giulia Galli, Sabrina Borgetto, Sabrina Basso, Jessica Bagnarino, Chiara Pulvirenti, Patrizia Comoli et al. · 2023 · Cancers
Analysis of immune‐related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
Chengu Niu, Kaiwen Zhu, Jing Zhang, Utsav Joshi, Hongli Liu, Salman Zahid, Nagesh Jadhav, Patrick I. Okolo III · 2023 · International Journal of Cancer
Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer
Brian D. Griffith, Jenny Lazarus, Jake J. McGue, Santhoshi Krishnan, Michael Ian D'Angelica, Jinru Shia, Irina Y. Dobrosotskaya, Jiaqi Shi, Jacob Edwards, Arvind U.K. Rao et al. · 2023 · Frontiers in Immunology
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer – Outcome and novel predictive markers
Amos Stemmer, Ofer Margalit, Victoria Serpas, Gal Zvi Strauss, Jane Varkey Thomas, Preksha Shah, Noam Tau, Keren Levanon, Einat Shacham‐Shmueli, Scott Kopetz et al. · 2023 · European Journal of Cancer
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China
Wang Qu, Zimin Liu, Xiaobing Chen, Bo Liu, Yunbo Zhao, Hao Yan, Xiujuan Qu, Shengmian Li, Aimin Zang, Yongkun Sun et al. · 2024 · BMC Cancer
Shikonin improves the effectiveness of PD-1 blockade in colorectal cancer by enhancing immunogenicity via Hsp70 upregulation
Jinghua Chen, Jie Liu, Xiaolin Liu, Jun Wang, Xiumei Wang, Xin Ye, Qi Xie, Jing Liang, Yan Li · 2024 · Molecular Biology Reports
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal Cancer—An Overview of Current Status and Future Perspectives
Wilhelm Graf, Lana Ghanipour, Helgi Birgisson, Peter Cashin · 2024 · Cancers
Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers
Zaki H. Hakami · 2024 · Pathology - Research and Practice
Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer
Dongliang Chen, Nuo Chen, Hui Sheng, Dongsheng Zhang · 2024 · Cancer Drug Resistance
CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer
Kota Okuno, Kyonosuke Ikemura, Riku Okamoto, Keiko Oki, Akiko Watanabe, Yu Kuroda, Mikiko Kidachi, Shiori Fujino, Yusuke Nie, Tadashi Higuchi et al. · 2024 · PLoS ONE
Molecular Landscape and Therapeutic Strategies against Colorectal Cancer
Aakash Patel, Pat Gulhati · 2024 · Cancers